A Phase II Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Patients With BPH

Clinical trial NCT02855892 · COMPLETED

Trial details

NCT number: NCT02855892
Sponsor: GemVax & Kael
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Benign Prostatic Hyperplasia (BPH)

Start date: 2015-10-01
Primary completion: 2016-10-01
Enrollment: 161

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.